优良速生树种中山杉的国内外研究现状

中山杉的优良特性备受国内外学者的关注。国内有不少关于中山杉的研究报道,学者们从不同层次研究中山杉的优良特性,以更好的利用中山杉,发挥其生态、效益和经济效益。本文从中山杉的来源、抗逆性、育苗技术、景观及推广应用等几个方面对近年来中山杉的研究进展进行介绍,以期为中山杉资源的综合开发利用提供依据。     

7株牛源A型巴氏杆菌的分离鉴定及耐药性分析

对2014年沈阳地区患有呼吸系统疾病的育肥牛场进行病原分离,得到7株分离菌,对其进行培养形态及染色观察、病理组织切片观察、动物致病性观察及16S序列分析,初步鉴定为牛多杀性巴氏杆菌(Pm)。利用Pm种特异性引物及荚膜血清特异性引物进行PCR扩增,均得到目的基因条带。对分离菌进行药敏试验的结果显示,5株分离菌株已对阿米卡星、新诺明产生较强耐药性;7株分离菌均对氟苯尼考、恩诺沙星、四环素及氨苄西林敏感。由此确定,分离菌株均为牛荚膜A型巴氏杆菌,且已具有一定耐药性。     

‘热引19号’坚尼草选育研究报告

1998年从澳大利亚引入坚尼草TD58(Panicum maximum‘TD58')后,相继完成适应性评价、品种比较试验、区域试验和生产试验,2007年选育而成‘热引19号'坚尼草(P.maximum'Reyin NO.19')。结果表明:该品种年均干草产量达21753.02 kg·hm~(-2),种子年均产量为800.05 kg·hm~(-2),营养价值适中,且耐低温、耐荫、耐旱、花期晚,综合性状均优于对照品种,是适合于我国南方热带亚热带地区推广种植的牧草新品种。     

鲈鱼摩氏摩根菌的鉴定及药敏试验

从患病鲈鱼体内分离到1株优势菌LY2014,对其进行形态观察、生理生化试验、16SrDNA基因序列分析,同时采用Kriby-Bauer纸片扩散法进行耐药性分析。结果该菌为发酵型、具有动力的革兰阴性杆菌,根据生化试验结果初步确定该菌为摩氏摩根菌。以该菌的基因组为模板PCR扩增获得的16SrDNA序列长度为1 407bp(GenBank登入号为KJ830813)。该序列与GenBank数据库中摩氏摩根菌的16SrDNA基因序列相似性高达99%,系统进化树显示其与摩氏摩根菌亲缘关系最近,从而确定菌株LY2014为摩氏摩根菌。该菌株对磷霉素、菌必治和多黏霉素B高度敏感,对痢特灵、红霉素和诺氟沙星等5种药物中度敏感,对氨苄西林和氟苯尼考等11种药物耐药。     

北京地区奶牛隐性乳房炎金黄色葡萄球菌的分离鉴定及药敏试验

为了解北京地区奶牛隐性乳房炎中金黄色葡萄球菌的感染情况及对常用药物的敏感性,用科玛嘉显色培养基和16SrRNA PCR检测方法对5个奶牛场的100份隐性乳房炎奶样进行金黄色葡萄球菌的分离鉴定,采用K-B纸片扩增法进行药敏试验。结果表明,显色培养基分离到24株疑似金黄色葡萄球菌,经16SrRNA PCR鉴定,15株为金黄色葡萄球菌;药敏试验结果显示,15株金黄色葡萄球菌均对β-内酰胺类中的氨苄西林产生普遍耐药性,对克林霉素和环丙沙星的耐药率较高,分别为53.33%和40%;对氧氟沙星、庆大霉素、头孢噻肟和头孢曲松的耐药性较低,耐药率为6.67%。说明15株金黄色葡萄球菌分离株对7类9种抗菌药物都有不同程度的耐药性。     

饲用小黑麦在海河平原区的生产性能及适应性评价

在海河平原区对11个饲用小黑麦品种进行了生产性能比较试验以及旱作条件下适应性,试验得出:冀饲-1成熟早,生育期短,抽穗期比对照中新830提前6d,干草产量高,比对照中新830提高26.7%,能与春播作物形成一年两作,适于在海河平原区推广利用;冀饲-2在海河平原地区鲜干草产量均较高,分别比对照中新830增产4 854.3kg/hm2和777.0kg/hm2,属于高产品种,茎叶比低,叶量丰富是海河平原区主要品种推广种植。旱作条件下种植,饲用小黑麦株高比正常管理条件下降低64.6%~83.4%,分蘖数和成穗数分别减少60.0%~74.7%和85.3%~98.1%,鲜干草产量分别降低69.3%和70.2%,利用价值不大,只有在一定的灌溉和施肥条件下种植才能产生较好经济效益。     

Pyrantel resistance in two herds of donkey in the UK

Resistance to currently available anthelmintics is a serious phenomenon which is prevalent globally. Cyathostomins are one of the major parasites, and are of primary concern in donkeys. There have been reports of emerging resistance to pyrantel, but the status of pyrantel resistance in donkey populations in the UK is largely unknown. This report investigates pyrantel resistance in two geographically isolated donkey herds in the South West of England. The first herd had suspected pyrantel resistance, with already established resistance to other anthelmintics. In the second herd the efficacy of pyrantel was not suspected at the time the study took place. Faecal Egg Count Reduction Test (FECRT) was carried out, revealing large scale resistance. Eighty one percent of the first herd and 73% of the second herd had a FEC of less than 95% after treatment, and anthelmintic resistance was confirmed using the World Association for the Advancement of Veterinary Parasitology guidelines. These findings indicate that anthelmintic resistance to pyrantel exists in both tested donkey populations and illustrate the continuing development of resistance through different classes of chemotherapeutics.     

Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines

Canine histiocytic sarcoma (HS) is an aggressive tumor type originating from histiocytic cell lineages. This disease is characterized by poor response to chemotherapy and short survival time. Therefore, it is of critical importance to identify and develop effective antitumor drugs against HS. The objectives of this study were to examine the drug sensitivities of 10 antitumor drugs. Using a real-time RT-PCR system, the mRNA expression levels of 16 genes related to drug resistance in 4 canine HS cell lines established from dogs with disseminated HS were determined and compared to 2 canine lymphoma cell lines (B-cell and T-cell). These 4 canine HS cell lines showed sensitivities toward microtubule inhibitors (vincristine, vinblastine and paclitaxel), comparable to those in the canine B-cell lymphoma cell line. Moreover, it was shown that P-gp in the HS cell lines used in this study did not have enough function to efflux its substrate. Sensitivities to melphalan, nimustine, methotrexate, cytarabine, doxorubicin and etoposide were lower in the 4 HS cell lines than in the 2 canine lymphoma cell lines. The data obtained in this study using cultured cell lines could prove helpful in the developing of advanced and effective chemotherapies for treating dogs that are suffering from HS.